Gene · 220
Papers1,919
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 1,919
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting Gastric Cancer Stem Cells to Enhance Treatment Response. | Cells | 2022 | 36139403 | PubTator, text mining | PubMed |
| Natural Products-Based Nanoformulations: A New Approach Targeting CSCs to Cancer Therapy. | Int J Nanomedicine | 2022 | 36134202 | PubTator, text mining | PubMed |
| TWIST1 induces proteasomal degradation of β-catenin during the differentiation of ovarian cancer stem-like cells. | Sci Rep | 2022 | 36123378 | PubTator, text mining | PubMed |
| Evaluation of CD44+/CD24- and Aldehyde Dehydrogenase Enzyme Markers in Cancer Stem Cells as Prognostic Indicators for Triple-Negative Breast Cancer. | Cureus | 2022 | 36120232 | PubTator, text mining | PubMed |
| Therapeutic Targeting of Cancer Stem Cells Prevents Resistance of Colorectal Cancer Cells to MEK Inhibition. | ACS Pharmacol Transl Sci | 2022 | 36110381 | PubTator, text mining | PubMed |
| Prolonged, Low-Level Exposure to the Marine Toxin, Domoic Acid, and Measures of Neurotoxicity in Nonhuman Primates. | Environ Health Perspect | 2022 | 36102641 | PubTator, text mining | PubMed |
| A lipid metabolism-related risk signature for patients with gliomas constructed with TCGA and CGGA data. | Medicine (Baltimore) | 2022 | 36086728 | PubTator, text mining | PubMed |
| Identification of EZH2 as Cancer Stem Cell Marker in Clear Cell Renal Cell Carcinoma and the Anti-Tumor Effect of Epigallocatechin-3-Gallate (EGCG). | Cancers (Basel) | 2022 | 36077742 | PubTator, text mining | PubMed |
| Targeting PI3K/AKT/mTOR Signaling Pathway in Pancreatic Cancer: From Molecular to Clinical Aspects. | Int J Mol Sci | 2022 | 36077529 | PubTator, text mining | PubMed |
| Expression of aldehyde dehydrogenase 1A1 in oral squamous cell carcinoma and its correlation with clinicopathological parameters. | Natl J Maxillofac Surg | 2022 | 36051794 | PubTator, text mining | PubMed |
| Curcumin-based-fluorescent probes targeting ALDH1A3 as a promising tool for glioblastoma precision surgery and early diagnosis. | Commun Biol | 2022 | 36050388 | PubTator, text mining | PubMed |
| Long-term culture of patient-derived cardiac organoids recapitulated Duchenne muscular dystrophy cardiomyopathy and disease progression. | Front Cell Dev Biol | 2022 | 36035984 | PubTator, text mining | PubMed |
| Comprehensive analysis of androgen receptor status in prostate cancer with neuroendocrine differentiation. | Front Oncol | 2022 | 36033483 | PubTator, text mining | PubMed |
| Impact of Non-Pharmacological Interventions on the Mechanisms of Atherosclerosis. | Int J Mol Sci | 2022 | 36012362 | PubTator, text mining | PubMed |
| Cancer Stem Cell Markers in Rhabdomyosarcoma in Children. | Diagnostics (Basel) | 2022 | 36010245 | PubTator, text mining | PubMed |
| Di(2-ethylhexyl) phthalate induced thyroid toxicity via endoplasmic reticulum stress: In vivo and in vitro study. | Environ Toxicol | 2022 | 36005737 | PubTator, text mining | PubMed |
| Ovo Like Zinc Finger 2 (OVOL2) Suppresses Breast Cancer Stem Cell Traits and Correlates with Immune Cells Infiltration. | Breast Cancer (Dove Med Press) | 2022 | 35996562 | PubTator, text mining | PubMed |
| Identification of key genes for hypertrophic cardiomyopathy using integrated network analysis of differential lncRNA and gene expression. | Front Cardiovasc Med | 2022 | 35990977 | PubTator, text mining | PubMed |
| Large-scale transcriptomic analysis of coding and non-coding pathological biomarkers, associated with the tumor immune microenvironment of thyroid cancer and potential target therapy exploration. | Front Cell Dev Biol | 2022 | 35990603 | PubTator, text mining | PubMed |
| Tumor associated macrophages-derived exosomes facilitate hepatocellular carcinoma malignance by transferring lncMMPA to tumor cells and activating glycolysis pathway. | J Exp Clin Cancer Res | 2022 | 35986343 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/220/papers?page=21